123 related articles for article (PubMed ID: 20436521)
1. Toxoplasmosis in allo-SCT patients: risk factors and outcomes at a transplantation center with a low incidence.
Mulanovich VE; Ahmed SI; Öztürk T; Khokhar FA; Kontoyiannis DP; de Lima M
Bone Marrow Transplant; 2011 Feb; 46(2):273-7. PubMed ID: 20436521
[TBL] [Abstract][Full Text] [Related]
2. Early detection of Toxoplasma infection by molecular monitoring of Toxoplasma gondii in peripheral blood samples after allogeneic stem cell transplantation.
Martino R; Bretagne S; Einsele H; Maertens J; Ullmann AJ; Parody R; Schumacher U; Pautas C; Theunissen K; Schindel C; Muñoz C; Margall N; Cordonnier C;
Clin Infect Dis; 2005 Jan; 40(1):67-78. PubMed ID: 15614694
[TBL] [Abstract][Full Text] [Related]
3. Toxoplasmosis after allogeneic stem cell transplantation--a single centre experience.
Busemann C; Ribback S; Zimmermann K; Sailer V; Kiefer T; Schmidt CA; Schulz K; Steinmetz I; Dombrowski F; Dölken G; Krüger WH
Ann Hematol; 2012 Jul; 91(7):1081-9. PubMed ID: 22249208
[TBL] [Abstract][Full Text] [Related]
4. Incidence of Viral and fungal infections following busulfan-based reduced-intensity versus myeloablative conditioning in pediatric allogeneic stem cell transplantation recipients.
Satwani P; Baldinger L; Freedman J; Jacobson JS; Guerra J; van de Ven C; Morris E; Garvin J; George D; Bradley MB; Bhatia M; Tallamy B; Schwartz J; Jin Z; Cairo MS
Biol Blood Marrow Transplant; 2009 Dec; 15(12):1587-95. PubMed ID: 19896083
[TBL] [Abstract][Full Text] [Related]
5. Adenoviral infection after allogeneic stem cell transplantation (SCT): report on 130 patients from a single SCT unit involved in a prospective multi center surveillance study.
Runde V; Ross S; Trenschel R; Lagemann E; Basu O; Renzing-Köhler K; Schaefer UW; Roggendorf M; Holler E
Bone Marrow Transplant; 2001 Jul; 28(1):51-7. PubMed ID: 11498744
[TBL] [Abstract][Full Text] [Related]
6. Impact of cyclosporine-A concentration on the incidence of severe acute graft-versus-host disease after allogeneic stem cell transplantation.
Malard F; Szydlo RM; Brissot E; Chevallier P; Guillaume T; Delaunay J; Ayari S; Dubruille V; Le Gouill S; Mahe B; Gastinne T; Blin N; Saulquin B; Harousseau JL; Moreau P; Mohty M
Biol Blood Marrow Transplant; 2010 Jan; 16(1):28-34. PubMed ID: 20053329
[TBL] [Abstract][Full Text] [Related]
7. Diagnosis of toxoplasmosis after allogeneic stem cell transplantation: results of DNA detection and serological techniques.
Fricker-Hidalgo H; Bulabois CE; Brenier-Pinchart MP; Hamidfar R; Garban F; Brion JP; Timsit JF; Cahn JY; Pelloux H
Clin Infect Dis; 2009 Jan; 48(2):e9-e15. PubMed ID: 19072243
[TBL] [Abstract][Full Text] [Related]
8. Toxoplasmosis with hemophagocytic syndrome after bone marrow transplantation: diagnosis at autopsy.
Duband S; Cornillon J; Tavernier E; Dumollard JM; Guyotat D; Péoc'h M
Transpl Infect Dis; 2008 Oct; 10(5):372-4. PubMed ID: 18384483
[TBL] [Abstract][Full Text] [Related]
9. Assessment of disseminated adenovirus infections using quantitative plasma PCR in adult allogeneic stem cell transplant recipients receiving reduced intensity or myeloablative conditioning.
Kalpoe JS; van der Heiden PL; Barge RM; Houtzager S; Lankester AC; van Tol MJ; Kroes AC
Eur J Haematol; 2007 Apr; 78(4):314-21. PubMed ID: 17331130
[TBL] [Abstract][Full Text] [Related]
10. Severe pulmonary toxoplasmosis after allo-SCT in two patients: from Toxoplasma genotyping to clinical management.
Delhaes L; Mraz JC; Fréalle E; Durand-Joly I; Magro L; Ajzenberg D; Dardé ML; Dei-Cas E; Yakoub-Agha I
Bone Marrow Transplant; 2010 Mar; 45(3):580-3. PubMed ID: 19597419
[No Abstract] [Full Text] [Related]
11. Myeloablative conditioning predisposes patients for Toxoplasma gondii reactivation after allogeneic stem cell transplantation.
Meers S; Lagrou K; Theunissen K; Dierickx D; Delforge M; Devos T; Janssens A; Meersseman W; Verhoef G; Van Eldere J; Maertens J
Clin Infect Dis; 2010 Apr; 50(8):1127-34. PubMed ID: 20218875
[TBL] [Abstract][Full Text] [Related]
12. Outpatient reduced-intensity allogeneic stem cell transplantation for patients with refractory or relapsed lymphomas compared with autologous stem cell transplantation using a simplified method.
Gutiérrez-Aguirre CH; Ruiz-Argüelles G; Cantú-Rodríguez OG; González-Llano O; Jaime-Pérez JC; García-Rodríguez F; López-Otero A; Herrera-Garza JL; Gómez-Almaguer D
Ann Hematol; 2010 Oct; 89(10):1045-52. PubMed ID: 20490794
[TBL] [Abstract][Full Text] [Related]
13. Toxoplasmosis after hematopoietic stem cell transplantation.
Martino R; Maertens J; Bretagne S; Rovira M; Deconinck E; Ullmann AJ; Held T; Cordonnier C
Clin Infect Dis; 2000 Nov; 31(5):1188-95. PubMed ID: 11073751
[TBL] [Abstract][Full Text] [Related]
14. [Development of a real-time PCR assay for quantitative diagnosis of Toxoplasma gondii after allogeneic bone marrow transplantation].
Daval S; Poirier P; Armenaud J; Cambon M; Livrelli V
Pathol Biol (Paris); 2010 Feb; 58(1):104-9. PubMed ID: 19892493
[TBL] [Abstract][Full Text] [Related]
15. Conventional allogeneic hematopoietic stem cell transplantation for lymphoma may overcome the poor prognosis associated with a positive FDG-PET scan before transplantation.
Yoshimi A; Izutsu K; Takahashi M; Kako S; Oshima K; Kanda Y; Motokura T; Chiba S; Momose T; Ohtomo K; Kurokawa M
Am J Hematol; 2008 Jun; 83(6):477-81. PubMed ID: 18266206
[TBL] [Abstract][Full Text] [Related]
16. [Cytomegalovirus diseases after allogeneic hematopoietic stem cell transplantation (Allo-HSCT) and related risk factors].
Huang XJ; Xu LP; Ren HY; Zhang YC; Guo NL; Lu DP
Zhonghua Yi Xue Za Zhi; 2003 May; 83(9):766-9. PubMed ID: 12899755
[TBL] [Abstract][Full Text] [Related]
17. A prospective study of diagnosis of Toxoplasma gondii infection after bone marrow transplantation.
Edvinsson B; Lundquist J; Ljungman P; Ringdén O; Evengård B
APMIS; 2008 May; 116(5):345-51. PubMed ID: 18452424
[TBL] [Abstract][Full Text] [Related]
18. Anemia associated with impaired erythropoietin secretion after allogeneic stem cell transplantation: incidence, risk factors, and response to treatment.
Gaya A; Urbano-Ispizua A; Fernández-Avilés F; Salamero O; Roncero JM; Rovira M; Martínez C; Talarn C; Granell M; Carreras E; Montserrat E
Biol Blood Marrow Transplant; 2008 Aug; 14(8):880-7. PubMed ID: 18640571
[TBL] [Abstract][Full Text] [Related]
19. Inverse relationship between human herpesvirus-6 and -7 detection after allogeneic and autologous stem cell transplantation.
Miyoshi H; Tanaka-Taya K; Hara J; Fujisaki H; Matsuda Y; Ohta H; Osugi Y; Okada S; Yamanishi K
Bone Marrow Transplant; 2001 May; 27(10):1065-70. PubMed ID: 11438822
[TBL] [Abstract][Full Text] [Related]
20. Early infections in adults undergoing matched related and matched unrelated/mismatched donor stem cell transplantation: a comparison of incidence.
van Kraaij MG; Verdonck LF; Rozenberg-Arska M; Dekker AW
Bone Marrow Transplant; 2002 Sep; 30(5):303-9. PubMed ID: 12209352
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
